FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats.
Lewis recipients of orthotopic ACI livers had permanent graft acceptance induced with 3 doses of i.m. FK506 in the early postoperative period. They were studied 100 and 300 days posttransplantation. The recipients rejected ACI as well as Brown Norway (BN) (third-party) skin grafts, and had lymphocytes with substantial reactivity by mixed lymphocyte culture testing against ACI and third-party (BN) alloantigens. Lymphocyte subset redistribution had not occurred in the peripheral blood or spleens of these animals, and there was no evidence of suppressor cell activation by in vitro and in vivo tests. Graft-versus-host reactivity in splenic lymphoid tissues of these recipients was demonstrated with the popliteal lymph node assay. Attempts at adaptive transfer with recipient lymphocytes were unsuccessful. Heart graft acceptance was far more difficult to accomplish than liver graft acceptance, and probably was never permanent. ACI heart graft prolongation in LEW recipients after a brief induction with FK506 lasted for no more than 3 months in most animals. The temporary heart graft acceptance was specific for hearts of the original ACI donor strain but not for ACI skin. Results of studies of lymphocyte subsets and suppressor cell activity were similar to those in the liver recipients. These studies illustrate how poorly graft acceptance is understood and how badly further work is needed to clarify its mechanism.
Department of Surgery, University Health Center of Pittsburgh, University of Pittsburgh, Pennsylvania.
N
N
Murase
D G
DG
Kim
S
S
Todo
D V
DV
Cramer
J
J
Fung
T E
TE
Starzl
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006084:Graft Rejection / Q000187:drug effects*; D016027:Heart Transplantation / Q000379:methods*; D007166:Immunosuppressive Agents; D016219:Immunotherapy, Adoptive; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D016559:Tacrolimus; D014184:Transplantation, Homologous
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus